1 Mikhael, J., Bhutani, M., & Cole, C. E. (2023). Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations. The American journal of medicine, 136(1), 33–41. https://doi.org/10.1016/j.amjmed.2022.08.030
2 Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., Landgren, O., Paiva, B., Dispenzieri, A., Weiss, B., LeLeu, X., Zweegman, S., Lonial, S., Rosinol, L., Zamagni, E., Jagannath, S., … Miguel, J. F. (2014). International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. The Lancet. Oncology, 15(12), e538–e548. https://doi.org/10.1016/S1470-2045(14)70442-5
3 Howell, D., Smith, A., Appleton, S., Bagguley, T., Macleod, U., Cook, G., Patmore, R., & Roman, E. (2017). Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population-based study. British journal of haematology, 177(1), 67–71. https://doi.org/10.1111/bjh.14513
4 International Myeloma Foundation. (2025). What Are MGUS, Smoldering and Active Myeloma? Geraadpleegd van: https://www.myeloma.org/what-are-mgus-smm-mm
5 Kyle, R. A., Durie, B. G., Rajkumar, S. V., Landgren, O., Blade, J., Merlini, G., Kröger, N., Einsele, H., Vesole, D. H., Dimopoulos, M., San Miguel, J., Avet-Loiseau, H., Hajek, R., Chen, W. M., Anderson, K. C., Ludwig, H., Sonneveld, P., Pavlovsky, S., Palumbo, A., Richardson, P. G., … International Myeloma Working Group (2010). Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia, 24(6), 1121–1127. https://doi.org/10.1038/leu.2010.60
6 Binding Site. (2025). Multiple Myeloma Diagnosis Criteria for Primary Care Providers Geraadpleegd van: https://www.thermofisher.com/bindingsite/wo/en/expert-insights/multiple-myeloma-diagnosis-criteria.html
